Tiotropium + Olodaterol

tiotropium/olodaterol · Boehringer Ingelheim and Novo Nordisk

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Tiotropium + Olodaterol, covering 2015-09-15 to 2024-12-04. Get the full timeline:

Most recent: Clinical Trial Update: Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data

See pricing